The U.S. Centers for Disease Control and Prevention (CDC) said earlier today that coronavirus testing is now available in 78 state and local laboratories across all 50 states.
The agency has 75K test kits for public lab use
with more available soon according to Dr. Nancy Messonnier, director of
the CDC’s immunization and respiratory diseases unit.
Most of the testing will likely be done in the
private sector (all major reference labs are now online). The FDA will
allow the use of laboratory-developed tests (LDTs) as long as they are
verified by the CDC, while they wait for Emergency Use Authorization.
According to Johns Hopkins University, the number
of U.S. cases is now 560, although the number should spike since testing
is now widely available (in other words, the U.S. infection rate has
been underreported due to the paucity of COVID-19 tests).
Test-related tickers: Co-Diagnostics (CODX -20.1%), Chembio Diagnostics (CEMI -7.1%), OPKO Health (OPK -2.8%), LabCorp (LH -3.3%), Quest Diagnostics (DGX -2.3%), Abbott (ABT -6.2%), Roche (OTCQX:RHHBY-5.5%), Thermo Fisher Scientific (TMO -6.4%), Becton, Dickinson (BDX -3.8%), Luminex (LMNX +0.4%)
https://seekingalpha.com/news/3549837-coronavirus-testing-available-in-every-state-cdc
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.